We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Breakthrough POC Diagnostic Technology Detects Brain Abnormalities Prior to Symptoms

By HospiMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: Delphi-MD Neurodiagnostics Device (Photo courtesy of QuantalX)
Image: Delphi-MD Neurodiagnostics Device (Photo courtesy of QuantalX)

According to a study published in "The Lancet", 90% of strokes and 35% of dementias can be prevented if detected early enough, however diagnosis methods available today result in ineffective treatment of brain disorders due to late, inaccurate and under diagnosis. Additionally, 35% of the total economic disease burden is attributed to brain disorders, mostly due to repeated hospitalization and rehabilitation, avoidance of unnecessary CT/MRI scans and associated accessibility and cost challenges. Now, the world's first direct brain network visualization technology provides objective clinical measurements of neuronal functions for the first time, enabling point of care physicians and neurologists access to new diagnostics capabilities.

Quantalx Neuroscience, Inc. (Raanana, Israel) has developed Delphi-MD, an "ECG" for the brain, which provides direct brain network visualization, enabling clinical measurements of neuronal functions for the first time in healthcare history. For clinicians, such a brain health revolutionizing technology, accessible at the point of care, dramatically supports early and differential diagnosis through "real life" objective data, leading to informed treatment decisions and interventions, as well as improving brain health outcomes for healthcare providers and payors. For patients, an earlier diagnosis leads to an optimal care pathway, resulting in a positive, long-term effect on quality of life.

"The clinical breakthrough of Delphi-MD is that it is a direct, functional, objective test for the brain, that does not require patient participation and provides actionable insight to the physician at the point of care," said Dr. Iftach Dolev, CEO and Co-Founder of QuantalX. "Making neuro-diagnosis accessible to everyone is game changing for brain health management"

Related Links:
QuantalX Neuroscience, Inc.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.